Key facts
- This page summarizes Heather Rees's Form 3 filing for ATOSSA THERAPEUTICS, INC. (ATOS).
- 0 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 16 Oct 2023, 16:00.
Heather Rees - 06 Oct 2023 Form 3 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)
- Reporting relationship
- SVP, Finance and Accounting
- Issuer ticker
- ATOS
- Reported as of
- 06 Oct 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 Oct 2023, 16:00:20 UTC
- Next SEC filing
- 01 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Heather Rees
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Heather Rees filed Form 3 for ATOSSA THERAPEUTICS, INC. (ATOS) on 16 Oct 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATOS
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 32,500
- Exercise price
- $1.48
- Footnotes
- F1
ATOS
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,500
- Exercise price
- $3.18
- Footnotes
- F1
ATOS
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 129,700
- Exercise price
- $2.90
- Footnotes
- F1
ATOS
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $3.18
- Footnotes
- F1
ATOS
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 150,000
- Exercise price
- $0.9300
- Footnotes
- F2
ATOS
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 226,000
- Exercise price
- $0.9200
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The options are fully vested.
Footnote F2
The options vest in equal quarterly installments over a period of two years from the grant date, May 13, 2022, subject to the Reporting Person's continued service to Issuer through each vesting date.
Footnote F3
The options vest in equal quarterly installments over a period of two years from the grant date, June 12, 2023, subject to the Reporting Person's continued service to Issuer through each vesting date.
SEC remarks
Exhibit 24 - Power of Attorney